<qa>  What is the current use of entanercept, tildrakizuma- Previous use of entanercept, tildrakizumab MK-3222, or other interleukin-23 IL-23T- helper cell 17 Th-17 pathway inhibitors including p40, p19, and IL-17 antagonists 